Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy Sanford C. Bernstein

Start price
€852.00
17.10.24 / 50%
Target price
€1,014.1
17.10.25
Performance (%)
-19.44%
End price
€686.40
18.10.25
Summary
This prediction ended on 18.10.25 with a price of €686.40. The prediction for Eli Lilly Corp. disappointed with a performance of -19.44%. Sanford_C__Bernstein has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €2.66 are taken into consideration when calculating the performance. Sanford_C__Bernstein has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Eli Lilly Corp. 0.922% 0.922% 17.157%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Sanford_C__Bernstein for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) -19.44%
Target price 1014.090
Change
Ends at 17.10.25

Eli Lilly and Company (NYSE: LLY) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,100.00 price target on the stock.
Ratings data for LLY provided by MarketBeat

In the thread Trading Eli Lilly Corp.
Prediction Buy
Perf. (%) -19.44%
Target price 1014.090
Change
Ends at 17.10.25

Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten

Current prediction by Sanford_C__Bernstein for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€760.50
03.11.25
-
03.11.26
15.11%
12.12.25